Calorite 50mg Oral Suspension

About this Medicine

Calorite 50mg Oral Suspension belongs to a class of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDS). These have pain and fever-reducing properties. It is used for the treatment of acute pain and fever both in infants and children. Adhere to the prescribed dose, time, and way while giving Calorite 50mg Oral Suspension to your child. It can be given orally before or after meals. However, it is best to give this medicine to your child after meals as this will prevent the chance of developing an upset stomach. Avoid giving more than the recommended dose for fast relief as that may cause unwanted effects in your child. If your child vomits within 30 minutes of taking this medicine, give the same dose again but do skip it if it's time for the next dose.Calorite 50mg Oral Suspension may cause side effects like nausea, vomiting, stomach pain, heartburn, diarrhea, and allergy after taking this medicine. These side effects are temporary and are likely to subside once your child’s body adapts to the medicine. In case they persist or become bothersome for your child, do consult your child’s doctor on a priority basis.Before administering Calorite 50mg Oral Suspension to your child, do inform the doctor if your child is allergic to any medicine or products, or has a history of any heart problems, birth defects, liver disease, kidney disease, lung disease, or bleeding disorder. This information is critical for dose alteration and helps in planning your child's overall treatment.Note: As per the Ministry of Health and Family Welfare, Calorite 50mg Oral Suspension is banned for children under 12 years of age.

How it Works

Calorite 50mg Oral Suspension works by blocking the action of a chemical messenger, prostaglandin, in the body which is responsible for pain, fever, and inflammation (redness and swelling).

Key Facts

Chemical Class :: Diphenylethers Derivative|Habit Forming :: No|Therapeutic Class :: PAIN ANALGESICS|Action Class :: NSAID's-Non-Selective COX 1&2 Inhibitors (Others)

Safety Overview